Selected research
Industry Research
Plasmid DNA Production & Manufacturing Service Industry Research Report 2026
Market perspective
The global Plasmid DNA Production & Manufacturing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Plasmid DNA Production & Manufacturing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Plasmid DNA Production & Manufacturing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Plasmid DNA Production & Manufacturing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Plasmid DNA Production & Manufacturing Service include Charles River Laboratories, VGXI, Inc., Danaher (Aldevron), Kaneka Corp., Nature Technology, Cell and Gene Therapy Catapult, Eurofins Genomics, Lonza and Luminous BioSciences, LLC and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Plasmid DNA Production & Manufacturing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Plasmid DNA Production & Manufacturing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plasmid DNA Production & Manufacturing Service Market by Company
Charles River Laboratories
VGXI, Inc.
Danaher (Aldevron)
Kaneka Corp.
Nature Technology
Cell and Gene Therapy Catapult
Eurofins Genomics
Lonza
Luminous BioSciences, LLC
Akron Biotech
Plasmid DNA Production & Manufacturing Service Segment by Type
R&D Grade
GMP Grade
Plasmid DNA Production & Manufacturing Service Segment by Application
DNA Vaccines
Cell & Gene Therapy
Immunotherapy
Others
Plasmid DNA Production & Manufacturing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasmid DNA Production & Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasmid DNA Production & Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasmid DNA Production & Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Plasmid DNA Production & Manufacturing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- R&D Grade
- GMP Grade
Applications
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
Companies covered
- Charles River Laboratories
- VGXI, Inc.
- Danaher (Aldevron)
- Kaneka Corp.
- Nature Technology
- Cell and Gene Therapy Catapult
- Eurofins Genomics
- Lonza
- Luminous BioSciences, LLC
- Akron Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Plasmid DNA Production & Manufacturing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 R&D Grade
- 2.2.3 GMP Grade
- 2.3 Plasmid DNA Production & Manufacturing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 DNA Vaccines
- 2.3.3 Cell & Gene Therapy
- 2.3.4 Immunotherapy
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Plasmid DNA Production & Manufacturing Service Breakdown Data by Type
- 3.1 Global Plasmid DNA Production & Manufacturing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Plasmid DNA Production & Manufacturing Service Forecasted Market Size by Type (2027-2032)
4 Plasmid DNA Production & Manufacturing Service Breakdown Data by Application
- 4.1 Global Plasmid DNA Production & Manufacturing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Plasmid DNA Production & Manufacturing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Plasmid DNA Production & Manufacturing Service Market Perspective (2021-2032)
- 5.2 Global Plasmid DNA Production & Manufacturing Service Growth Trends by Region
- 5.2.1 Global Plasmid DNA Production & Manufacturing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Plasmid DNA Production & Manufacturing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Plasmid DNA Production & Manufacturing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Plasmid DNA Production & Manufacturing Service Market Dynamics
- 5.3.1 Plasmid DNA Production & Manufacturing Service Industry Trends
- 5.3.2 Plasmid DNA Production & Manufacturing Service Market Drivers
- 5.3.3 Plasmid DNA Production & Manufacturing Service Market Challenges
- 5.3.4 Plasmid DNA Production & Manufacturing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Plasmid DNA Production & Manufacturing Service Players by Revenue
- 6.1.1 Global Top Plasmid DNA Production & Manufacturing Service Players by Revenue (2021-2026)
- 6.1.2 Global Plasmid DNA Production & Manufacturing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Plasmid DNA Production & Manufacturing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Plasmid DNA Production & Manufacturing Service Head Office and Area Served
- 6.4 Global Plasmid DNA Production & Manufacturing Service Players, Product Type & Application
- 6.5 Global Plasmid DNA Production & Manufacturing Service Manufacturers Established Date
- 6.6 Global Plasmid DNA Production & Manufacturing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Plasmid DNA Production & Manufacturing Service Market Size (2021-2032)
- 7.2 North America Plasmid DNA Production & Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Plasmid DNA Production & Manufacturing Service Market Size by Country (2021-2026)
- 7.4 North America Plasmid DNA Production & Manufacturing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Plasmid DNA Production & Manufacturing Service Market Size (2021-2032)
- 8.2 Europe Plasmid DNA Production & Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Plasmid DNA Production & Manufacturing Service Market Size by Country (2021-2026)
- 8.4 Europe Plasmid DNA Production & Manufacturing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Plasmid DNA Production & Manufacturing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Plasmid DNA Production & Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Plasmid DNA Production & Manufacturing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Plasmid DNA Production & Manufacturing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Plasmid DNA Production & Manufacturing Service Market Size (2021-2032)
- 10.2 South America Plasmid DNA Production & Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Plasmid DNA Production & Manufacturing Service Market Size by Country (2021-2026)
- 10.4 South America Plasmid DNA Production & Manufacturing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Plasmid DNA Production & Manufacturing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Plasmid DNA Production & Manufacturing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Plasmid DNA Production & Manufacturing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Plasmid DNA Production & Manufacturing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River Laboratories
- 12.1.1 Charles River Laboratories Company Information
- 12.1.2 Charles River Laboratories Business Overview
- 12.1.3 Charles River Laboratories Revenue in Plasmid DNA Production & Manufacturing Service Business (2021-2026)
- 12.1.4 Charles River Laboratories Plasmid DNA Production & Manufacturing Service Product Portfolio
- 12.1.5 Charles River Laboratories Recent Developments
- 12.2 VGXI, Inc.
- 12.2.1 VGXI, Inc. Company Information
- 12.2.2 VGXI, Inc. Business Overview
- 12.2.3 VGXI, Inc. Revenue in Plasmid DNA Production & Manufacturing Service Business (2021-2026)
- 12.2.4 VGXI, Inc. Plasmid DNA Production & Manufacturing Service Product Portfolio
- 12.2.5 VGXI, Inc. Recent Developments
- 12.3 Danaher (Aldevron)
- 12.3.1 Danaher (Aldevron) Company Information
- 12.3.2 Danaher (Aldevron) Business Overview
- 12.3.3 Danaher (Aldevron) Revenue in Plasmid DNA Production & Manufacturing Service Business (2021-2026)
- 12.3.4 Danaher (Aldevron) Plasmid DNA Production & Manufacturing Service Product Portfolio
- 12.3.5 Danaher (Aldevron) Recent Developments
- 12.4 Kaneka Corp.
- 12.4.1 Kaneka Corp. Company Information
- 12.4.2 Kaneka Corp. Business Overview
- 12.4.3 Kaneka Corp. Revenue in Plasmid DNA Production & Manufacturing Service Business (2021-2026)
- 12.4.4 Kaneka Corp. Plasmid DNA Production & Manufacturing Service Product Portfolio
- 12.4.5 Kaneka Corp. Recent Developments
- 12.5 Nature Technology
- 12.5.1 Nature Technology Company Information
- 12.5.2 Nature Technology Business Overview
- 12.5.3 Nature Technology Revenue in Plasmid DNA Production & Manufacturing Service Business (2021-2026)
- 12.5.4 Nature Technology Plasmid DNA Production & Manufacturing Service Product Portfolio
- 12.5.5 Nature Technology Recent Developments
- 12.6 Cell and Gene Therapy Catapult
- 12.6.1 Cell and Gene Therapy Catapult Company Information
- 12.6.2 Cell and Gene Therapy Catapult Business Overview
- 12.6.3 Cell and Gene Therapy Catapult Revenue in Plasmid DNA Production & Manufacturing Service Business (2021-2026)
- 12.6.4 Cell and Gene Therapy Catapult Plasmid DNA Production & Manufacturing Service Product Portfolio
- 12.6.5 Cell and Gene Therapy Catapult Recent Developments
- 12.7 Eurofins Genomics
- 12.7.1 Eurofins Genomics Company Information
- 12.7.2 Eurofins Genomics Business Overview
- 12.7.3 Eurofins Genomics Revenue in Plasmid DNA Production & Manufacturing Service Business (2021-2026)
- 12.7.4 Eurofins Genomics Plasmid DNA Production & Manufacturing Service Product Portfolio
- 12.7.5 Eurofins Genomics Recent Developments
- 12.8 Lonza
- 12.8.1 Lonza Company Information
- 12.8.2 Lonza Business Overview
- 12.8.3 Lonza Revenue in Plasmid DNA Production & Manufacturing Service Business (2021-2026)
- 12.8.4 Lonza Plasmid DNA Production & Manufacturing Service Product Portfolio
- 12.8.5 Lonza Recent Developments
- 12.9 Luminous BioSciences, LLC
- 12.9.1 Luminous BioSciences, LLC Company Information
- 12.9.2 Luminous BioSciences, LLC Business Overview
- 12.9.3 Luminous BioSciences, LLC Revenue in Plasmid DNA Production & Manufacturing Service Business (2021-2026)
- 12.9.4 Luminous BioSciences, LLC Plasmid DNA Production & Manufacturing Service Product Portfolio
- 12.9.5 Luminous BioSciences, LLC Recent Developments
- 12.10 Akron Biotech
- 12.10.1 Akron Biotech Company Information
- 12.10.2 Akron Biotech Business Overview
- 12.10.3 Akron Biotech Revenue in Plasmid DNA Production & Manufacturing Service Business (2021-2026)
- 12.10.4 Akron Biotech Plasmid DNA Production & Manufacturing Service Product Portfolio
- 12.10.5 Akron Biotech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst